跳至主要内容
临床试验/EUCTR2004-004516-22-SE
EUCTR2004-004516-22-SE进行中(未招募)不适用

The impact of steroid hormones on symptom provocation in patients with premenstrual dysphoric disorder.

ppsala University0 个研究点目标入组 30 人开始时间: 2004年11月25日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
发起方
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
Female

入选标准

  • 1. Diagnosed premenstrual dysphoric disorder
  • 2. Age between 18 and 45 years
  • 3. Regular menstrual cycles (between 25 - 31 days)
  • 4. Informed consent
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years)
  • F.1.3.1 Number of subjects for this age range

排除标准

  • 1. Pregnant or breastfeeding
  • 2. Use of oral contraceptives, progestagens, antiandrogens or any other hormones during the last 6 months.
  • 3. Use of antidepressants, benozodiazepines or any other compound with central nervous system effects during the last 2 months.
  • 4. Personal or family history of thromboembolism.
  • 5. High blod pressure (>145/90)
  • 6. Ongoing psychiatric disorder according to M.I.N.I. structured psychiatric interview.
  • 7. Report of physical or psychological violence by the patient.

研究者

发起方
ppsala University

相似试验